Literature DB >> 34809786

Osteochondroma Pathogenesis: Mouse Models and Mechanistic Insights into Interactions with Retinoid Signaling.

Sonia Arely Garcia1, Vincent Y Ng1, Masahiro Iwamoto1, Motomi Enomoto-Iwamoto2.   

Abstract

Osteochondromas are cartilage-capped tumors that arise near growing physes and are the most common benign bone tumor in children. Osteochondromas can lead to skeletal deformity, pain, loss of motion, and neurovascular compression. Currently, surgery is the only available treatment for symptomatic osteochondromas. Osteochondroma mouse models have been developed to understand the pathology and the origin of osteochondromas and develop therapeutic drugs. Several cartilage regulatory pathways have been implicated in the development of osteochondromas, such as bone morphogenetic protein, hedgehog, and WNT/β-catenin signaling. Retinoic acid receptor-γ is an important regulator of endochondral bone formation. Selective agonists for retinoic acid receptor-γ, such as palovarotene, have been investigated as drugs for inhibition of ectopic endochondral ossification, including osteochondromas. This review discusses the signaling pathways involved in osteochondroma pathogenesis and their possible interactions with the retinoid pathway.
Copyright © 2021 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cartilage tumor; Endochondral ossification; Growth plate; Osteochondroma; Retinoids

Mesh:

Substances:

Year:  2021        PMID: 34809786      PMCID: PMC8647428          DOI: 10.1016/j.ajpath.2021.08.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

Review 1.  Heparan sulfate proteoglycan - A common receptor for diverse cytokines.

Authors:  Meng Xie; Jin-Ping Li
Journal:  Cell Signal       Date:  2018-11-27       Impact factor: 4.315

2.  Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.

Authors:  Toshihiro Inubushi; Isabelle Lemire; Fumitoshi Irie; Yu Yamaguchi
Journal:  J Bone Miner Res       Date:  2017-11-30       Impact factor: 6.741

Review 3.  Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses.

Authors:  Julianne Huegel; Federica Sgariglia; Motomi Enomoto-Iwamoto; Eiki Koyama; John P Dormans; Maurizio Pacifici
Journal:  Dev Dyn       Date:  2013-07-29       Impact factor: 3.780

4.  Mice deficient in Ext2 lack heparan sulfate and develop exostoses.

Authors:  Dominique Stickens; Beverly M Zak; Nathalie Rougier; Jeffrey D Esko; Zena Werb
Journal:  Development       Date:  2005-10-19       Impact factor: 6.868

5.  Direct inhibition of Indian hedgehog expression by parathyroid hormone (PTH)/PTH-related peptide and up-regulation by retinoic acid in growth plate chondrocyte cultures.

Authors:  E Yoshida; M Noshiro; T Kawamoto; S Tsutsumi; Y Kuruta; Y Kato
Journal:  Exp Cell Res       Date:  2001-04-15       Impact factor: 3.905

Review 6.  Nuclear retinoid receptors and the transcription of retinoid-target genes.

Authors:  Julie Bastien; Cécile Rochette-Egly
Journal:  Gene       Date:  2004-03-17       Impact factor: 3.688

7.  Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate.

Authors:  Mauricio Cortes; Alexis T Baria; Nancy B Schwartz
Journal:  Development       Date:  2009-04-15       Impact factor: 6.868

Review 8.  Hereditary multiple exostoses and enchondromatosis.

Authors:  Stéphanie Pannier; Laurence Legeai-Mallet
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

9.  BMP action in skeletogenesis involves attenuation of retinoid signaling.

Authors:  Lisa M Hoffman; Kamal Garcha; Konstantina Karamboulas; Matthew F Cowan; Linsay M Drysdale; William A Horton; T Michael Underhill
Journal:  J Cell Biol       Date:  2006-07-03       Impact factor: 10.539

Review 10.  Heparan sulfate proteoglycans: a sugar code for vertebrate development?

Authors:  Fabienne E Poulain; H Joseph Yost
Journal:  Development       Date:  2015-10-15       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.